PURPOSE: Medical therapies for treatment of peripheral artery disease (PAD) are limited. Ginkgo biloba has been reported to increase maximal and pain-free walking distance among patients with PAD; however, the evidence is inconsistent. The objective of this study was to compare the effects of 300 mg/d of Ginkgo biloba (EGb 761) versus placebo on treadmill walking time and related cardiovascular measures among patients with PAD. METHODS: A double-blind, placebo-controlled, parallel design trial with a 4-month duration was used. Participants were 62 adults, aged 70 +/- 8 years (mean +/- SD), with claudication symptoms of PAD. The primary study outcomes were maximal and pain-free walking time on a treadmill. Secondary outcomes included flow-mediated vasodilation, a measure of antioxidant status as assessed by determining antibody levels to epitopes of oxidized low-density lipoprotein, and questionnaires addressing walking impairment and quality of life. RESULTS:Maximal treadmill walking time increased by 20 +/- 80 and 91 +/- 242 seconds in the placebo and the EGb 761 groups, respectively (P = .12). Pain-free walking time increased by 15 +/- 31 and 21 +/- 43 seconds, respectively (P = .28). No significant differences were detected between groups for any of the secondary outcomes. CONCLUSIONS: In older adults with PAD, Ginkgo biloba produced a modest but insignificant increase in maximal treadmill walking time and flow-mediated vasodilation. These data do not support the use of Ginkgo biloba as an effective therapy for PAD, although a longer duration of use should be considered in any future trials.
RCT Entities:
PURPOSE: Medical therapies for treatment of peripheral artery disease (PAD) are limited. Ginkgo biloba has been reported to increase maximal and pain-free walking distance among patients with PAD; however, the evidence is inconsistent. The objective of this study was to compare the effects of 300 mg/d of Ginkgo biloba (EGb 761) versus placebo on treadmill walking time and related cardiovascular measures among patients with PAD. METHODS: A double-blind, placebo-controlled, parallel design trial with a 4-month duration was used. Participants were 62 adults, aged 70 +/- 8 years (mean +/- SD), with claudication symptoms of PAD. The primary study outcomes were maximal and pain-free walking time on a treadmill. Secondary outcomes included flow-mediated vasodilation, a measure of antioxidant status as assessed by determining antibody levels to epitopes of oxidized low-density lipoprotein, and questionnaires addressing walking impairment and quality of life. RESULTS: Maximal treadmill walking time increased by 20 +/- 80 and 91 +/- 242 seconds in the placebo and the EGb 761 groups, respectively (P = .12). Pain-free walking time increased by 15 +/- 31 and 21 +/- 43 seconds, respectively (P = .28). No significant differences were detected between groups for any of the secondary outcomes. CONCLUSIONS: In older adults with PAD, Ginkgo biloba produced a modest but insignificant increase in maximal treadmill walking time and flow-mediated vasodilation. These data do not support the use of Ginkgo biloba as an effective therapy for PAD, although a longer duration of use should be considered in any future trials.
Authors: Jessica Rodenburg; Maud N Vissers; Albert Wiegman; Elizabeth R Miller; Paul M Ridker; Joseph L Witztum; John J P Kastelein; Sotirios Tsimikas Journal: J Am Coll Cardiol Date: 2006-04-17 Impact factor: 24.094
Authors: Anna Maria Izquierdo-Porrera; Andrew W Gardner; Douglas D Bradham; Polly S Montgomery; John D Sorkin; Claudia C Powell; Leslie I Katzel Journal: J Vasc Surg Date: 2005-04 Impact factor: 4.268
Authors: Saskia P A Nicolaï; Lotte M Kruidenier; Bianca L W Bendermacher; Martin H Prins; Rutger A Stokmans; Pieter P H L Broos; Joep A W Teijink Journal: Cochrane Database Syst Rev Date: 2013-06-06
Authors: José G Napolitano; Tanja Gödecke; María F Rodríguez-Brasco; Birgit U Jaki; Shao-Nong Chen; David C Lankin; Guido F Pauli Journal: J Nat Prod Date: 2012-02-14 Impact factor: 4.050
Authors: Lewis H Kuller; Diane G Ives; Annette L Fitzpatrick; Michelle C Carlson; Carla Mercado; Oscar L Lopez; Gregory L Burke; Curt D Furberg; Steven T DeKosky Journal: Circ Cardiovasc Qual Outcomes Date: 2009-11-24
Authors: Gabriele G Schiattarella; Cinzia Perrino; Fabio Magliulo; Andreina Carbone; Antonio G Bruno; Michele De Paulis; Antonio Sorropago; Roberto V Corrado; Roberta Bottino; Giovanni Menafra; Raffaele Abete; Evelina Toscano; Giuseppe Giugliano; Bruno Trimarco; Giovanni Esposito Journal: Front Physiol Date: 2014-03-03 Impact factor: 4.566